406 related articles for article (PubMed ID: 24830303)
1. Nanoparticle-based drug delivery to the vagina: a review.
Ensign LM; Cone R; Hanes J
J Control Release; 2014 Sep; 190():500-14. PubMed ID: 24830303
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves J; Amiji M; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
[TBL] [Abstract][Full Text] [Related]
3. Advanced topical drug delivery system for the management of vaginal candidiasis.
Johal HS; Garg T; Rath G; Goyal AK
Drug Deliv; 2016; 23(2):550-63. PubMed ID: 24959937
[TBL] [Abstract][Full Text] [Related]
4. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.
Ndesendo VM; Pillay V; Choonara YE; Buchmann E; Bayever DN; Meyer LC
AAPS PharmSciTech; 2008; 9(2):505-20. PubMed ID: 18431651
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides.
Sánchez-López E; Gómara MJ; Haro I
Curr Med Chem; 2021; 28(22):4356-4379. PubMed ID: 33297908
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers For Vaginal Drug Delivery.
Iqbal Z; Dilnawaz F
Recent Pat Drug Deliv Formul; 2019; 13(1):3-15. PubMed ID: 30767755
[TBL] [Abstract][Full Text] [Related]
7. Polymer-based nanocarriers for vaginal drug delivery.
das Neves J; Nunes R; Machado A; Sarmento B
Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling.
Sims LB; Frieboes HB; Steinbach-Rankins JM
Int J Nanomedicine; 2018; 13():2709-2727. PubMed ID: 29760551
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
10. Clinical safety issues in developing & testing of vaginal microbicides.
Joshi S; Mehendale S
Indian J Med Res; 2006 Jan; 123(1):5-8. PubMed ID: 16567859
[No Abstract] [Full Text] [Related]
11. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
12. Vaginal microbicides.
McCormack S
Curr Opin Infect Dis; 2002 Feb; 15(1):57-62. PubMed ID: 11964907
[TBL] [Abstract][Full Text] [Related]
13. Freeze-dried cylinders carrying chitosan nanoparticles for vaginal peptide delivery.
Marciello M; Rossi S; Caramella C; Remuñán-López C
Carbohydr Polym; 2017 Aug; 170():43-51. PubMed ID: 28522002
[TBL] [Abstract][Full Text] [Related]
14. Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications.
Li WZ; Hao XL; Zhao N; Han WX; Zhai XF; Zhao Q; Wang YE; Zhou YQ; Cheng YC; Yue YH; Fu LN; Zhou JL; Wu HY; Dong CJ
J Control Release; 2016 Mar; 226():107-14. PubMed ID: 26883754
[TBL] [Abstract][Full Text] [Related]
15. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles.
D'Cruz OJ; Uckun FM
Contraception; 2001 Aug; 64(2):113-23. PubMed ID: 11704088
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
Refai H; Hassan D; Abdelmonem R
Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
[TBL] [Abstract][Full Text] [Related]
17. Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art.
Leyva-Gómez G; Piñón-Segundo E; Mendoza-Muñoz N; Zambrano-Zaragoza ML; Mendoza-Elvira S; Quintanar-Guerrero D
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882846
[TBL] [Abstract][Full Text] [Related]
18. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
[TBL] [Abstract][Full Text] [Related]
20. Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.
Steinbach JM
Cell Mol Life Sci; 2015 Feb; 72(3):469-503. PubMed ID: 25323132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
